TOKYO, Dec 24 (Reuters) - Takeda Pharmaceutical Co Ltd, Japan’s top drugmaker, said on Wednesday the U.S. Food and Drug Administration would complete a review of a key diabetes drug candidate by June 26, 2009.
TOKYO, Dec 24 (Reuters) - Takeda Pharmaceutical Co Ltd, Japan’s top drugmaker, said on Wednesday the U.S. Food and Drug Administration would complete a review of a key diabetes drug candidate by June 26, 2009.
